JP2002540789A5 - - Google Patents

Download PDF

Info

Publication number
JP2002540789A5
JP2002540789A5 JP2000609567A JP2000609567A JP2002540789A5 JP 2002540789 A5 JP2002540789 A5 JP 2002540789A5 JP 2000609567 A JP2000609567 A JP 2000609567A JP 2000609567 A JP2000609567 A JP 2000609567A JP 2002540789 A5 JP2002540789 A5 JP 2002540789A5
Authority
JP
Japan
Prior art keywords
seq
cdna sequence
determined cdna
clone
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000609567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002540789A (ja
JP4806124B2 (ja
Filing date
Publication date
Priority claimed from US09/285,480 external-priority patent/US6590076B1/en
Priority claimed from US09/339,338 external-priority patent/US6573368B2/en
Priority claimed from US09/389,681 external-priority patent/US6518237B1/en
Priority claimed from US09/433,826 external-priority patent/US6579973B1/en
Application filed filed Critical
Publication of JP2002540789A publication Critical patent/JP2002540789A/ja
Publication of JP2002540789A5 publication Critical patent/JP2002540789A5/ja
Application granted granted Critical
Publication of JP4806124B2 publication Critical patent/JP4806124B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000609567A 1999-04-02 2000-02-15 乳癌の処置および診断のための組成物ならびにそれらの使用方法 Expired - Fee Related JP4806124B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US09/285,480 1999-04-02
US09/285,480 US6590076B1 (en) 1999-04-02 1999-04-02 Compositions for the treatment and diagnosis of breast cancer and methods for their use
US09/339,338 1999-06-23
US09/339,338 US6573368B2 (en) 1998-12-28 1999-06-23 Compositions for the treatment and diagnosis of breast cancer and methods for their use
US09/389,681 1999-09-02
US09/389,681 US6518237B1 (en) 1998-12-28 1999-09-02 Compositions for treatment and diagnosis of breast cancer and methods for their use
US09/433,826 US6579973B1 (en) 1998-12-28 1999-11-03 Compositions for the treatment and diagnosis of breast cancer and methods for their use
US09/433,826 1999-11-03
PCT/US2000/005308 WO2000060076A2 (en) 1999-04-02 2000-02-15 Compositions for the treatment and diagnosis of breast cancer and methods for their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010125855A Division JP2010239970A (ja) 1999-04-02 2010-06-01 乳癌の処置および診断のための組成物ならびにそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2002540789A JP2002540789A (ja) 2002-12-03
JP2002540789A5 true JP2002540789A5 (enExample) 2007-04-05
JP4806124B2 JP4806124B2 (ja) 2011-11-02

Family

ID=27804894

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000609567A Expired - Fee Related JP4806124B2 (ja) 1999-04-02 2000-02-15 乳癌の処置および診断のための組成物ならびにそれらの使用方法
JP2010125855A Pending JP2010239970A (ja) 1999-04-02 2010-06-01 乳癌の処置および診断のための組成物ならびにそれらの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010125855A Pending JP2010239970A (ja) 1999-04-02 2010-06-01 乳癌の処置および診断のための組成物ならびにそれらの使用方法

Country Status (5)

Country Link
US (2) US6590076B1 (enExample)
JP (2) JP4806124B2 (enExample)
AT (1) ATE514780T1 (enExample)
ES (1) ES2368899T3 (enExample)
ZA (1) ZA200108065B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU647741B2 (en) * 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7414112B2 (en) * 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
EP1248800A2 (en) * 1999-11-30 2002-10-16 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US6774226B1 (en) * 1999-11-30 2004-08-10 Ludwig Institute For Cancer Research Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
WO2002022777A2 (fr) * 2000-09-15 2002-03-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Genes cellulaires impliques dans l'oncogenese, les produits de ces genes et leurs applications diagnostiques et therapeutiques
JP4772688B2 (ja) * 2003-11-13 2011-09-14 ザ バーナム インスティチュート メタドヘリンポリペプチドとそのコード核酸及び使用方法
US20100160275A1 (en) * 2006-09-26 2010-06-24 Lee Eva Y H P Methods and compositions for cancer prevention and treatment
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US10294454B2 (en) 2016-08-24 2019-05-21 General Electric Company Methods and kits for cell activation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2613988A (en) 1988-01-04 1989-08-01 E.I. Du Pont De Nemours And Company Multiple stage affinity process for isolation of specific cells from a cell mixture
US5215926A (en) 1988-06-03 1993-06-01 Cellpro, Inc. Procedure for designing efficient affinity cell separation processes
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
DE69126620T2 (de) 1990-10-18 1997-10-02 Cellpro Inc Vorrichtung und verfahren zur trennung von partikeln mittels eines biegsamen gefässes
US5240856A (en) 1991-10-23 1993-08-31 Cellpro Incorporated Apparatus for cell separation
AU5310296A (en) 1995-03-17 1996-10-08 John Wayne Cancer Institute Detection of melanoma or breast metastases with a multiple marker assay
US5986170A (en) 1995-11-13 1999-11-16 Corixa Corporation Murine model for human carcinoma
US5891857A (en) 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
ATE364089T1 (de) * 1996-10-31 2007-06-15 Abbott Lab Reagenzien und methoden zum nachweis von erkrankungen der brust
AU7180198A (en) 1996-11-12 1998-06-03 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
WO1998033915A1 (en) 1997-02-03 1998-08-06 Human Genome Sciences, Inc. Breast cancer specific gene 1
WO1998054963A2 (en) 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins
WO1999009155A1 (en) 1997-08-19 1999-02-25 Human Genome Sciences, Inc. 70 human secreted proteins
EP0986643A1 (en) * 1997-06-20 2000-03-22 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
JP3422776B2 (ja) 1998-08-04 2003-06-30 ダイアデクスアス・インコーポレーテッド 乳癌を診断、監視、病期決定、造影及び治療する新規な方法
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
JP2002540761A (ja) * 1999-01-21 2002-12-03 アボット・ラボラトリーズ 乳房の疾患を検出するために有用な試薬と方法
EP1259812A2 (en) 1999-05-28 2002-11-27 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
WO2001037779A2 (en) 1999-11-23 2001-05-31 Diadexus, Inc. A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
JP5640237B2 (ja) 1999-11-30 2014-12-17 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ リミテッド 癌関連抗原をコードする単離された核酸分子、その抗原そのものおよびその使用

Similar Documents

Publication Publication Date Title
EP1183348B1 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
EP1169347B1 (en) Compounds and methods for therapy and diagnosis of lung cancer
EP1141290B1 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
EP1097208A2 (en) Compositions and methods for therapy and diagnosis of prostate cancer
JP2002540790A (ja) 肺癌の治療および診断のための化合物ならびにその使用のための方法
JP2010239970A (ja) 乳癌の処置および診断のための組成物ならびにそれらの使用方法
WO2001025272A2 (en) Compositions and methods for therapy and diagnosis of prostate cancer
EP1715043A2 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
CA2383615A1 (en) Methods for diagnosis and therapy of hematological and virus-associated malignancies
WO2001073027A2 (en) Compositions and methods for therapy and diagnosis of colon cancer
CA2460014A1 (en) Spas-1 cancer antigen
JP2002540789A5 (enExample)
WO2001051513A2 (en) Ovarian tumor-associated sequences
US20020058292A1 (en) Ovarian tumor antigen and methods of use therefor
US6933363B1 (en) Compositions and methods for therapy and diagnosis of lung cancer
US20020064815A1 (en) Ovarian tumor antigen and methods of use therefor
US20020155468A1 (en) Ovarian tumor antigen and methods of use therefor
JP4942906B2 (ja) 卵巣癌の治療および診断のための組成物および方法
AU2007216683B2 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
AU2003271300B2 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
WO2001027276A2 (en) Dna sequences from breast tumor and uses thereof
CA2613125A1 (en) Compositions and methods for therapy and diagnosis of prostate cancer